Claret, Laurent <br/><br/>
Prediction of overall survival or progression free survival by disease control rate at week 8 is independent of ethnicity: Western versus Chinese patients with first-line non-small cell lung cancer treated with chemotherapy with or without bevacizumab.  [electronic resource] 

 -  Journal of clinical pharmacology  Mar 2014 
 - 253-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Bevacizumab<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Disease-Free Survival<br/>Humans<br/>Lung Neoplasms--blood<br/>Models, Biological<br/>Paclitaxel--administration & dosage<br/>Racial Groups<br/>Serum Albumin--analysis<br/>Treatment Outcome